Alteration of Streptococcus salivarius in Buccal Mucosa of Oral Lichen Planus and Controlled Clinical Trial in OLP Treatment

Gupta S, Jawanda MK (2015) Oral lichen planus: an update on etiology, pathogenesis, clinical presentation, diagnosis and management. Indian J Dermatol 60(3):222–229. https://doi.org/10.4103/0019-5154.156315

Aghbari SMH, Abushouk AI, Attia A, Elmaraezy A, Menshawy A, Ahmed MS, Elsaadany BA, Ahmed EM (2017) Malignant transformation of oral lichen planus and oral lichenoid lesions: a meta-analysis of 20095 patient data. Oral Oncol 68:92–102. https://doi.org/10.1016/j.oraloncology.2017.03.012

Alrashdan MS, Cirillo N, McCullough M (2016) Oral lichen planus: a literature review and update. Arch Dermatol Res 308(8):539–551. https://doi.org/10.1007/s00403-016-1667-2

Gupta S, Ghosh S, Gupta S (2017) Interventions for the management of oral lichen planus: a review of the conventional and novel therapies. Oral Dis 23(8):1029–1042. https://doi.org/10.1111/odi.12634

Kundu P, Blacher E, Elinav E, Pettersson S (2017) Our gut microbiome: the evolving inner self. Cell 171(7):1481–1493. https://doi.org/10.1016/j.cell.2017.11.024

Sears CL, Pardoll DM (2011) Perspective: alpha-bugs, their microbial partners, and the link to colon cancer. J Infect Dis 203(3):306–311. https://doi.org/10.1093/jinfdis/jiq061

Honda K, Littman DR (2016) The microbiota in adaptive immune homeostasis and disease. Nature 535(7610):75–84. https://doi.org/10.1038/nature18848

He Y, Gong D, Shi C, Shao F, Shi J, Fei J (2017) Dysbiosis of oral buccal mucosa microbiota in patients with oral lichen planus. Oral Dis 23(5):674–682. https://doi.org/10.1111/odi.12657

Wang K, Miao T, Lu W, He J, Cui B, Li J, Li Y, Xiao L (2015) Analysis of oral microbial community and Th17-associated cytokines in saliva of patients with oral lichen planus. Microbiol Immunol 59(3):105–113. https://doi.org/10.1111/1348-0421.12232

Wang K, Lu W, Tu Q, Ge Y, He J, Zhou Y, Gou Y, Van Nostrand JD, Qin Y, Li J, Zhou J, Li Y, Xiao L, Zhou X (2016) Preliminary analysis of salivary microbiome and their potential roles in oral lichen planus. Sci Rep 6:22943. https://doi.org/10.1038/srep22943

Ertugrul AS, Arslan U, Dursun R, Hakki SS (2013) Periodontopathogen profile of healthy and oral lichen planus patients with gingivitis or periodontitis. Int J Oral Sci 5(2):92–97. https://doi.org/10.1038/ijos.2013.30

Ma F, Zhou C, Wang J, Liu T, Liu J (2015) Probiotics in the treatment of peptic ulcer infected by Helicobacter pylory and its safety. Pak J Pharm Sci 28(3 Suppl):1087–1090

Fuchs-Tarlovsky V, Marquez-Barba MF, Sriram K (2016) Probiotics in dermatologic practice. Nutrition 32(3):289–295. https://doi.org/10.1016/j.nut.2015.09.001

Wescombe PA, Hale JD, Heng NC, Tagg JR (2012) Developing oral probiotics from Streptococcus salivarius. Future Microbiol 7(12):1355–1371. https://doi.org/10.2217/fmb.12.113

Zupancic K, Kriksic V, Kovacevic I, Kovacevic D (2017) Influence of oral probiotic Streptococcus salivarius K12 on ear and oral cavity health in humans: systematic review. Probiotics Antimicrob Proteins 9(2):102–110. https://doi.org/10.1007/s12602-017-9261-2

Ishijima SA, Hayama K, Burton JP, Reid G, Okada M, Matsushita Y, Abe S (2012) Effect of Streptococcus salivarius K12 on the in vitro growth of Candida albicans and its protective effect in an oral candidiasis model. Appl Environ Microbiol 78(7):2190–2199. https://doi.org/10.1128/aem.07055-11

Cosseau C, Devine DA, Dullaghan E, Gardy JL, Chikatamarla A, Gellatly S, Yu LL, Pistolic J, Falsafi R, Tagg J, Hancock RE (2008) The commensal Streptococcus salivarius K12 downregulates the innate immune responses of human epithelial cells and promotes host-microbe homeostasis. Infect Immun 76(9):4163–4175. https://doi.org/10.1128/iai.00188-08

Kaci G, Lakhdari O, Dore J, Ehrlich SD, Renault P, Blottiere HM, Delorme C (2011) Inhibition of the NF-kappaB pathway in human intestinal epithelial cells by commensal Streptococcus salivarius. Appl Environ Microbiol 77(13):4681–4684. https://doi.org/10.1128/aem.03021-10

Kramer IR, Lucas RB, Pindborg JJ, Sobin LH (1978) Definition of leukoplakia and related lesions: an aid to studies on oral precancer. Oral Surg Oral Med Oral Pathol 46(4):518–539

Hoshino T, Kawaguchi M, Shimizu N, Hoshino N, Ooshima T, Fujiwara T (2004) PCR detection and identification of oral streptococci in saliva samples using gtf genes. Diagn Microbiol Infect Dis 48(3):195–199. https://doi.org/10.1016/j.diagmicrobio.2003.10.002

Kaliakatsou F, Hodgson TA, Lewsey JD, Hegarty AM, Murphy AG, Porter SR (2002) Management of recalcitrant ulcerative oral lichen planus with topical tacrolimus. J Am Acad Dermatol 46(1):35–41. https://doi.org/10.1067/mjd.2002.120535

Malik U, Gupta S, Malik SD, Vashishth S, Zaheeruddin RMS (2012) Treatment of symptomatic oral lichen planus (OLP) with 0.1% tacrolimus powder in Oraguard-B - a pilot prospective study. Saudi Dent J 24(3–4):143–148. https://doi.org/10.1016/j.sdentj.2012.05.002

Mostafa D, Moussa E, Alnouaem M (2017) Evaluation of photodynamic therapy in treatment of oral erosive lichen planus in comparison with topically applied corticosteroids. Photodiagn Photodyn Ther 19:56–66. https://doi.org/10.1016/j.pdpdt.2017.04.014

Chamani G, Rad M, Zarei MR, Lotfi S, Sadeghi M, Ahmadi Z (2015) Efficacy of tacrolimus and clobetasol in the treatment of oral lichen planus: a systematic review and meta-analysis. Int J Dermatol 54(9):996–1004. https://doi.org/10.1111/ijd.12925

Momose F, Araida T, Negishi A, Ichijo H, Shioda S, Sasaki S (1989) Variant sublines with different metastatic potentials selected in nude mice from human oral squamous cell carcinomas. J Oral Pathol Med 18(7):391–395

Miyazaki Y, Yoshida N, Nozaki T, Inoue H, Kikuchi K, Kusama K (2015) Telomerase activity in the occurrence and progression of oral squamous cell carcinoma. J Oral Sci 57(4):295–303. https://doi.org/10.2334/josnusd.57.295

Takata H, Tomizawa K, Matsushita M, Matsui H (2004) 2-methoxyestradiol enhances p53 protein transduction therapy-associated inhibition of the proliferation of oral cancer cells through the suppression of NFkappaB activity. Acta med Okayama 58(4):181–187. https://doi.org/10.18926/amo/32086

Kaci G, Goudercourt D, Dennin V, Pot B, Dore J, Ehrlich SD, Renault P, Blottiere HM, Daniel C, Delorme C (2014) Anti-inflammatory properties of Streptococcus salivarius, a commensal bacterium of the oral cavity and digestive tract. Appl Environ Microbiol 80(3):928–934. https://doi.org/10.1128/aem.03133-13

Couvigny B, de Wouters T, Kaci G, Jacouton E, Delorme C, Dore J, Renault P, Blottiere HM, Guedon E, Lapaque N (2015) Commensal Streptococcus salivarius modulates PPARgamma transcriptional activity in human intestinal epithelial cells. PLoS One 10(5):e0125371. https://doi.org/10.1371/journal.pone.0125371

Round JL, Mazmanian SK (2009) The gut microbiota shapes intestinal immune responses during health and disease. Nat Rev Immunol 9(5):313–323. https://doi.org/10.1038/nri2515

Coyte KZ, Schluter J, Foster KR (2015) The ecology of the microbiome: networks, competition, and stability. Science 350(6261):663–666. https://doi.org/10.1126/science.aad2602

Laleman I, Detailleur V, Slot DE, Slomka V, Quirynen M, Teughels W (2014) Probiotics reduce mutans streptococci counts in humans: a systematic review and meta-analysis. Clin Oral Investig 18(6):1539–1552. https://doi.org/10.1007/s00784-014-1228-z

Seminario-Amez M, Lopez-Lopez J, Estrugo-Devesa A, Ayuso-Montero R, Jane-Salas E (2017) Probiotics and oral health: a systematic review. Med Oral Patol Oral Cir Bucal 22(3):e282–e288

Burton JP, Cowley S, Simon RR, McKinney J, Wescombe PA, Tagg JR (2011) Evaluation of safety and human tolerance of the oral probiotic Streptococcus salivarius K12: a randomized, placebo-controlled, double-blind study. Food Chem Toxicol 49(9):2356–2364. https://doi.org/10.1016/j.fct.2011.06.038

Di Pierro F, Risso P, Poggi E, Timitilli A, Bolloli S, Bruno M, Caneva E, Campus R, Giannattasio A (2018) Use of Streptococcus salivarius K12 to reduce the incidence of pharyngo-tonsillitis and acute otitis media in children: a retrospective analysis in not-recurrent pediatric subjects. Minerva Pediat 70(3):240–245. https://doi.org/10.23736/s0026-4946.18.05182-4

Humphreys GJ, McBain AJ (2019) Antagonistic effects of Streptococcus and Lactobacillus probiotics in pharyngeal biofilms. Lett Appl Microbiol 68(4):303–312. https://doi.org/10.1111/lam.13133

Masdea L, Kulik EM, Hauser-Gerspach I, Ramseier AM, Filippi A, Waltimo T (2012) Antimicrobial activity of Streptococcus salivarius K12 on bacteria involved in oral malodour. Arch Oral Biol 57(8):1041–1047. https://doi.org/10.1016/j.archoralbio.2012.02.011

Walker GV, Heng NC, Carne A, Tagg JR, Wescombe PA (2016) Salivaricin E and abundant dextranase activity may contribute to the anti-cariogenic potential of the probiotic candidate Streptococcus salivarius JH. Microbiology 162(3):476–486. https://doi.org/10.1099/mic.0.000237